Main > INFECTIOUS DISEASES > Bacteria Infectious Diseases+ > Bacillus Anthracis Infection > Treatment > Co: USA. E. ObiltoxaxiMAb Inj.

---

Co: USA. E. ObiltoxaxiMAb Inj.'s subsections
(*) USA Approval Date: 2016. 03.21.
Company
Patent>Assignee; Claims; No.; Etc.
Patent>UpDate: 2007. 05.22
Patent>USA Expiration: 2023. 07.15.
TradeMark
TradeMark Web-Site

Co: USA. E. ObiltoxaxiMAb Inj.'s products
This section has no products